The week in industry: First-in-class psoriasis treatment approved in China
This week: Lonza and Chr Hansen aim to position themselves as leaders in the live biotherapeutic product industry, the US FDA approves an IND application for the first allogeneic CAR-T to treat multiple myeloma patients and report shows 17 innovative sickle cell medicines are in development.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>